228 related articles for article (PubMed ID: 32967246)
1. Circulating MicroRNAs as Novel Biomarkers for Osteoporosis and Fragility Fracture Risk: Is There a Use in Assessment Risk?
Ciuffi S; Donati S; Marini F; Palmini G; Luzi E; Brandi ML
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32967246
[TBL] [Abstract][Full Text] [Related]
2. Circulating miRNAs: A New Opportunity in Bone Fragility.
Donati S; Ciuffi S; Palmini G; Brandi ML
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32570976
[TBL] [Abstract][Full Text] [Related]
3. Circulating MicroRNAs as Biomarkers of Osteoporosis and Fragility Fractures.
Ciuffi S; Marini F; Fossi C; Donati S; Giusti F; Botta A; Masi L; Isaia G; Marcocci C; Migliaccio S; Minisola S; Nuti R; Tarantino U; Iantomasi T; Brandi ML
J Clin Endocrinol Metab; 2022 Jul; 107(8):2267-2285. PubMed ID: 35532548
[TBL] [Abstract][Full Text] [Related]
4. Increased circulating microRNA-21 level as a potential indicator for predicting a higher risk of incident fragility fractures.
Si ZX; Zhou SF; Shen ZL; Yan JL
J Osteopath Med; 2024 Mar; 124(3):121-125. PubMed ID: 37883102
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs as novel biomarkers for bone diseases - Complex signatures for multifactorial diseases?
Hackl M; Heilmeier U; Weilner S; Grillari J
Mol Cell Endocrinol; 2016 Sep; 432():83-95. PubMed ID: 26525415
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNA Signatures in Patients With Idiopathic and Postmenopausal Osteoporosis and Fragility Fractures.
Kocijan R; Muschitz C; Geiger E; Skalicky S; Baierl A; Dormann R; Plachel F; Feichtinger X; Heimel P; Fahrleitner-Pammer A; Grillari J; Redl H; Resch H; Hackl M
J Clin Endocrinol Metab; 2016 Nov; 101(11):4125-4134. PubMed ID: 27552543
[TBL] [Abstract][Full Text] [Related]
7. Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures.
Aguado-Maestro I; Panteli M; García-Alonso M; Bañuelos-Díaz A; Giannoudis PV
Injury; 2017 Dec; 48 Suppl 7():S27-S33. PubMed ID: 28851521
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and diagnostic workup of the patient at risk to sustain fragility fracture.
Antoniadou E; Kouzelis A; Diamantakis G; Bavelou A; Panagiotopoulos E
Injury; 2017 Dec; 48 Suppl 7():S17-S23. PubMed ID: 28855082
[TBL] [Abstract][Full Text] [Related]
9. The utility of dual-energy X-ray absorptiometry, calcaneal quantitative ultrasound, and fracture risk indices (FRAX® and Osteoporosis Risk Assessment Instrument) for the identification of women with distal forearm or hip fractures: A pilot study.
Esmaeilzadeh S; Cesme F; Oral A; Yaliman A; Sindel D
Endocr Res; 2016 Aug; 41(3):248-60. PubMed ID: 26864472
[TBL] [Abstract][Full Text] [Related]
10. Measurement of cortical porosity of the proximal femur improves identification of women with nonvertebral fragility fractures.
Ahmed LA; Shigdel R; Joakimsen RM; Eldevik OP; Eriksen EF; Ghasem-Zadeh A; Bala Y; Zebaze R; Seeman E; Bjørnerem Å
Osteoporos Int; 2015 Aug; 26(8):2137-46. PubMed ID: 25876879
[TBL] [Abstract][Full Text] [Related]
11. We miss the opportunity: Pretreament of osteoporosis in a German trauma center.
Rausch V; Schwarzer A; Dietrich JW; Kaisler M; Seybold D; Vollert J; Schildhauer TA; Maier C
PLoS One; 2018; 13(11):e0207122. PubMed ID: 30418992
[TBL] [Abstract][Full Text] [Related]
12. ADDING VFA TO DXA IDENTIFIES FRACTURE RISK IN A WAY NOT DUPLICATED BY OTHER MEASURES.
Ginther JP; Ginther AW; Brodersen LD
Endocr Pract; 2017 Dec; 23(12):1375-1378. PubMed ID: 29019717
[TBL] [Abstract][Full Text] [Related]
13. Application of the World Health Organization Fracture Risk Assessment Tool to predict need for dual-energy X-ray absorptiometry scanning in postmenopausal women.
Chao AS; Chen FP; Lin YC; Huang TS; Fan CM; Yu YW
Taiwan J Obstet Gynecol; 2015 Dec; 54(6):722-5. PubMed ID: 26700992
[TBL] [Abstract][Full Text] [Related]
14. Validation of three tools for identifying painful new osteoporotic vertebral fractures in older Chinese men: bone mineral density, Osteoporosis Self-Assessment Tool for Asians, and fracture risk assessment tool.
Lin J; Yang Y; Fei Q; Zhang X; Ma Z; Wang Q; Li J; Li D; Meng Q; Wang B
Clin Interv Aging; 2016; 11():461-9. PubMed ID: 27217730
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs as potential diagnostic biomarkers for osteoporosis.
Mandourah AY; Ranganath L; Barraclough R; Vinjamuri S; Hof RV; Hamill S; Czanner G; Dera AA; Wang D; Barraclough DL
Sci Rep; 2018 May; 8(1):8421. PubMed ID: 29849050
[TBL] [Abstract][Full Text] [Related]
16. Fracture Risk Assessment Tool May Not Indicate Bone Fragility in Women With Type 2 Diabetes.
Ohira M; Suzuki S; Yoshida T; Koide H; Tanaka T; Tatsuno I
Am J Med Sci; 2020 Nov; 360(5):552-559. PubMed ID: 32376002
[TBL] [Abstract][Full Text] [Related]
17. Worldwide Fracture Prediction.
El-Hajj Fuleihan G; Chakhtoura M; Cauley JA; Chamoun N
J Clin Densitom; 2017; 20(3):397-424. PubMed ID: 28734709
[TBL] [Abstract][Full Text] [Related]
18. Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey.
Oka R; Ohira M; Suzuki S; Yoshida T; Koide H; Tanaka T; Tatsuno I
Endocr J; 2018 Feb; 65(2):193-202. PubMed ID: 29151451
[TBL] [Abstract][Full Text] [Related]
19. Bone-related Circulating MicroRNAs miR-29b-3p, miR-550a-3p, and miR-324-3p and their Association to Bone Microstructure and Histomorphometry.
Feichtinger X; Muschitz C; Heimel P; Baierl A; Fahrleitner-Pammer A; Redl H; Resch H; Geiger E; Skalicky S; Dormann R; Plachel F; Pietschmann P; Grillari J; Hackl M; Kocijan R
Sci Rep; 2018 Mar; 8(1):4867. PubMed ID: 29559644
[TBL] [Abstract][Full Text] [Related]
20. Recent methods for assessing osteoporosis and fracture risk.
Imai K
Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):48-59. PubMed ID: 24438541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
